-
ICMRA workshop on adapted COVID-19 vaccines
ICMRA workshop on adapted COVID-19 vaccines
-
ICMRA workshop on adapted COVID-19 vaccines
ICMRA workshop on adapted COVID-19 vaccines
Global regulators agree on key principles to adapt COVID-19 vaccines to tackle virus variants
-
Start of review for Imvanex
Start of review for Imvanex
-
Start of review for Imvanex
Start of review for Imvanex
EMA reviews data to extend use of smallpox vaccine Imvanex against monkeypox and recommends importing US vaccine to the EU as temporary measure
-
Call for companies to register their i-SPOC
Call for companies to register their i-SPOC
-
Call for companies to register their i-SPOC
Call for companies to register their i-SPOC
Marketing authorisation holders are invited to register their Industry Single Point of Contact on shortages in EMA’s IRIS platform. Deadline for registration is 2 September 2022
-
CHMP highlights: June 2022
CHMP highlights: June 2022
-
CHMP highlights: June 2022
CHMP highlights: June 2022
EMA's human medicines committee (CHMP) recommended 9 new medicines for approval in the EU at its June 2022 meeting
Information for you
Key content
Services & databases
-
List item
Clinical Trials website
-
List item
Account Management portal
-
List item
eSubmission
-
List item
EudraVigilance (human)
-
List item
EudraVigilance Veterinary
-
List item
Veterinary Medicines information website
-
List item
Suspected adverse drug reactions database
-
List item
Clinical data
-
List item
SPOR data management services
-
List item
Service Desk
-
List item
IRIS platform
-
List item
Public register of parallel distribution notices
-
List item
European Vaccination Information Portal